COM:ISOPLEXIS

Bruker Cellular Analysis

Stock

Last Close

0.76

20/03 20:00

Market Cap

30.28M

Beta: -

Volume Today

111.02K

Avg: -

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22
net income	-13.63M -	-23.26M 70.73%	-81.57M 250.62%	-106.00M 29.95%
depreciation and amortization	498K -	879K 76.51%	2.31M 162.46%	4.96M 114.95%
deferred income tax	244K -		5.01M -
stock based compensation	143K -	517K 261.54%	2.08M 302.90%	4.39M 110.95%
change in working capital	-2.22M -	-751K 66.14%	-14.69M 1,855.93%	-11.18M 23.88%
accounts receivables	-989K -	-76K 92.32%	-1.18M 1,450%	-700K 40.58%
inventory	-2.55M -	-762K 70.13%	-20.64M 2,609.32%	-12.37M 40.09%
accounts payables	827K -	659K 20.31%	2.70M 310.02%	-2.06M 176.05%
other working capital	495K -	-572K 215.56%	4.43M 874.83%	3.94M 11.08%
other non cash items	1K -	185K 18,400%	350K 89.19%	11.18M 3,095.43%
net cash provided by operating activities	-14.96M -	-22.43M 49.98%	-86.51M 285.61%	-96.64M 11.72%
investments in property plant and equipment	-2.18M -	-2.29M 5.37%	-24.22M 955.47%	-7.82M 67.74%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites	-2.18M -	-2.29M 5.37%	-24.22M 955.47%	-7.82M 67.74%
debt repayment	-72K -
common stock issued			116.25M -
common stock repurchased
dividends paid			-153.71M -
other financing activites	22.55M -	104.00M 361.13%	168.12M 61.65%	15.33M 90.88%
net cash used provided by financing activities	22.48M -	104.00M 362.61%	130.66M 25.63%	15.33M 88.27%
effect of forex changes on cash				26K -
net change in cash	5.34M -	79.27M 1,383.07%	19.93M 74.86%	-89.10M 547.18%
cash at beginning of period	22.03M -	27.37M 24.27%	106.64M 289.61%	126.57M 18.68%
cash at end of period	27.37M -	106.64M 289.61%	126.57M 18.68%	37.47M 70.40%
operating cash flow	-14.96M -	-22.43M 49.98%	-86.51M 285.61%	-96.64M 11.72%
capital expenditure	-2.18M -	-2.29M 5.37%	-24.22M 955.47%	-7.82M 67.74%
free cash flow	-17.14M -	-24.73M 44.31%	-110.73M 347.77%	-104.46M 5.67%

All numbers in (except ratios and percentages)